PT - JOURNAL ARTICLE AU - Kolic, Jelena AU - Sun, WenQing Grace AU - Cen, Haoning Howard AU - Ewald, Jessica AU - Rogalski, Jason C. AU - Sasaki, Shugo AU - Sun, Han AU - Rajesh, Varsha AU - Xia, Yi Han AU - Moravcova, Renata AU - Skovsø, Søs AU - Spigelman, Aliya F. AU - Manning Fox, Jocelyn E. AU - Lyon, James AU - Beet, Leanne AU - Xia, Jianguo AU - Lynn, Francis C. AU - Gloyn, Anna L. AU - Foster, Leonard J. AU - MacDonald, Patrick E. AU - Johnson, James D. TI - Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease AID - 10.1101/2023.05.24.23290298 DP - 2024 Jan 01 TA - medRxiv PG - 2023.05.24.23290298 4099 - http://medrxiv.org/content/early/2024/03/05/2023.05.24.23290298.short 4100 - http://medrxiv.org/content/early/2024/03/05/2023.05.24.23290298.full AB - Population level variation and molecular mechanisms behind insulin secretion in response to carbohydrate, protein, and fat remain uncharacterized despite ramifications for personalized nutrition. Here, we define prototypical insulin secretion dynamics in response to the three macronutrients in islets from 140 cadaveric donors, including those diagnosed with type 2 diabetes. While islets from the majority of donors exhibited the expected relative response magnitudes, with glucose being highest, amino acid moderate, and fatty acid small, 9% of islets stimulated with amino acid and 8% of islets stimulated with fatty acids had larger responses compared with high glucose. We leveraged this insulin response heterogeneity and used transcriptomics and proteomics to identify molecular correlates of specific nutrient responsiveness, as well as those proteins and mRNAs altered in type 2 diabetes. We also examine nutrient-responsiveness in stem cell-derived islet clusters and observe that they have dysregulated fuel sensitivity, which is a hallmark of functionally immature cells. Our study now represents the first comparison of dynamic responses to nutrients and multi-omics analysis in human insulin secreting cells. Responses of different people’s islets to carbohydrate, protein, and fat lay the groundwork for personalized nutrition.ONE-SENTENCE SUMMARY Deep phenotyping and multi-omics reveal individualized nutrient-specific insulin secretion propensity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a Canadian Institutes for Health Research (CIHR) operating grant (168857) to J.D.J., a CIHR Team Grant (ASD-179092/5-SRA-2021-1149-S-B) to P.E.M., F.C.L., J.X., L.J.F., and J.D.J, a CIHR-JDRF Team (ASD-173663/5-SRA-2020-1059-S-B) to F.C.L., P.E.M., and J.D.J, and the JDRF Centre of Excellence at UBC (3-COE-2022-1103-M-B). This work was funded by Wellcome Trust grants to A.L.G at Oxford (095101, 200837, 106130, 203141, NIH (U01-DK105535; U01-DK085545) and by the Wellcome Trust (200837) and NIH (UM-1DK126185) at Stanford. Proteomics infrastructure and analysis used in this study was supported by the UBC Life Sciences Institute, Canada Foundation for Innovation, BC Knowledge Development Fund, and Genome Canada/BC (PRO264). J.K. was individually supported by a Banting Fellowship from CIHR.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Human islets were isolated from pancreas of cadaveric human donors at the Alberta Diabetes Institute IsletCore and used with approval of the Human Research Ethics Board at the University of Alberta (Pro00013094; Pro00001754), the University of British Columbia (UBC) Clinical Research Ethics Board (H13-01865), the University of Oxford's Oxford Tropical Research Ethics Committee (OxTREC Ref.2-15), the Oxfordshire Regional Ethics Committee B (REC reference: 09/H0605/2), or by the Stanford Center for Biomedical Ethics (IRB Protocol: 57310). All families of organ donors provided written informed consent for use in research.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.